Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Researchers discover molecular link between diet and risk of cancer
An international team of researchers has identified a direct molecular link between meat and dairy…
ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab
An experimental vaccine, designed to enlist the body’s own immune system to target cancer cells,…
Aggressive melanoma cells at edge of tumours are key to cancer spread
Research led by Queen Mary University of London, UK, has revealed novel insights into the mechanisms…
Immune cell that drives breast cancer could be effective target in novel immunotherapies
- SABCS 2020: Breast cancer survivors are less likely to get pregnant, but often have healthy babies and good long-term health
- SABCS 2020: Some postmenopausal women with common breast cancer may forgo chemotherapy
- SABCS 2020: Under-recognition of symptoms may be common in breast cancer patients receiving radiation
Sperm changes documented years after chemotherapy
A Washington State University researcher has documented epigenetic changes in the sperm of men who underwent chemotherapy in their teens.…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.